ACL tears are one of the most common injuries for athletes and often they undergo surgery to reconstruct the ligament. However, a new study suggests a non-operative treatment could be an effective ...
Rhythm Pharmaceuticals, Inc. met primary endpoint in phase 3 TRANSCEND study, which used setmelanotide for the treatment of patients with acquired hypothalamic obesity. Regulatory submission of ...
July 9 (Reuters) - Rhythm Pharmaceuticals' (RYTM.O), opens new tab experimental drug helped patients with a rare form of obesity caused by brain damage cut weight in a small study, the drugmaker said ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback